Neutrophil/platelet engraftment and chimerism
| . | Related donor . | Unrelated donor . | CB . | ||
|---|---|---|---|---|---|
| BM . | PBSCs . | BM . | PBSCs . | ||
| Median time to neutrophil engraftment, d (range) | 24 (5-33) | 20 (14-26) | 19 (12-27) | 18 (11-28) | 20 (13-42) |
| Median time to platelet engraftment, d (range) | 0 (0-22) | 0 (0-17) | 19 (0-40) | 18 (11-71) | 43 (0-251) |
| Outcome/condition (no. of patients) | |||||
| Rejection | 1 | 0 | 2 | 0 | 1 |
| Death/relapse before engraftment | 0 | 0 | 1 | 0 | 2 |
| Partial chimerism | 1 | 0 | 1 | 2 | 1 |
| Full chimerism | 6 | 8 | 6 | 7 | 7 |
| Chimerism data missing | 0 | 0 | 0 | 0 | 1* |
| . | Related donor . | Unrelated donor . | CB . | ||
|---|---|---|---|---|---|
| BM . | PBSCs . | BM . | PBSCs . | ||
| Median time to neutrophil engraftment, d (range) | 24 (5-33) | 20 (14-26) | 19 (12-27) | 18 (11-28) | 20 (13-42) |
| Median time to platelet engraftment, d (range) | 0 (0-22) | 0 (0-17) | 19 (0-40) | 18 (11-71) | 43 (0-251) |
| Outcome/condition (no. of patients) | |||||
| Rejection | 1 | 0 | 2 | 0 | 1 |
| Death/relapse before engraftment | 0 | 0 | 1 | 0 | 2 |
| Partial chimerism | 1 | 0 | 1 | 2 | 1 |
| Full chimerism | 6 | 8 | 6 | 7 | 7 |
| Chimerism data missing | 0 | 0 | 0 | 0 | 1* |
One cord blood patient with AML in PR3 engrafted but relapsed at day 81. Chimerism data were not available.